This is a stock photograph involving brownies infused with cannabis, marijuana and its implications in America as it has just slowly been legalized and used for medicinal and medical purposes and what that means to our economy and culture. Credit: skodonnell
A Massachusetts cannabis company is celebrating National Brownie Day on Wednesday with what it believes is the “largest THC-infused brownie ever made."
MariMed Inc. said the massive confection is 3-feet-by-3-feet (.9-meters-by-.9 meters) square and 15 inches (38 centimeters) tall, weighs 850 pounds (385 kilograms), and contains 20,000 mg of THC.
The brownie was also made to celebrate the launch of the company's new line of cannabis-infused edibles, called Bubby’s Baked, according to a statement from the Norwood-based company that also has facilities in several other states.
What happens to the brownie now? Company spokesperson Howard Schacter said it will be sent to its Middleborough dispensary and ultimately sold to a medical marijuana patient. As to what the customer plans to do with it, Schacter couldn't say.
The purchase price is still being determined, he said.
We spoke with a farmer about how tariffs, trade policy, drought, and packer consolidation are reshaping the economics of American ranching and farming.
John Serafini, CEO of Hawkeye 360, breaks down the company’s 87% revenue growth, global demand for space-based intelligence and plans to scale its business.
Dan Niles, Founder and Portfolio Manager at Niles Investment Management, breaks down NVIDIA’s blowout earnings, 70% growth forecast and AI spending boom.
Edwin Cywinski, CEO of SunScout Holding Limited, explains how solar-powered robotic mowers are transforming lawn care and the company’s plans to scale.
Nathan Bomey, Business Reporter at Axios and author of The Axios Closer newsletter, explains why Wall Street is turning NVIDIA’s AI chips into financial assets.
Jamie Siminoff, Founder and Chief Inventor of Ring, explains the company’s new TAKE encryption standard and its push to put privacy and video data control first
Xavier Martinez, News Associate at The Wall Street Journal, breaks down Moderna’s mRNA ambitions, its pipeline beyond COVID-19 and the challenges ahead.
